Perhexiline Maleate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePerhexiline Maleate
Drug Alias Nameperhexiline顺丁烯二酸环已哌啶perhexilina马来酸环己哌啶perhexilinum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarnitine palmitoyltransferase 2 inhibitorsCarnitine palmitoyltransferase 1A inhibitors
TargetsCarnitine palmitoyltransferase 2Carnitine palmitoyltransferase 1A
Therapy Area/IndicationsAngina PectorisHeart Failure, DiastolicMyocardial Reperfusion Injury +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of OxfordUniversity Of BirminghamFlinders University +[5] 
Active IndicationsAngina Pectoris
Inactive IndicationsHeart Failure, DiastolicMyocardial Reperfusion InjuryCardiomyopathy, Hypertrophic, Familial +[6] 

Other Information

ATC CodeC08EX02
Related LinksWikipediaDrugBankKEGG